发明名称 |
Modulation of transthyretin expression |
摘要 |
Disclosed is a single-stranded modified oligonucleotide consisting of 20 to 30 linked nucleosides, wherein the modified oligonucleotide comprises: a gap segment consisting of linked deoxynucleosides; a 5’ wing segment consisting of linked nucleosides; and a 3’ wing segment consisting of linked nucleosides; wherein the gap segment is positioned between the 5’ wing segment and the 3’ wing segment and wherein each nucleoside of each wing segment comprises a modified sugar, and wherein the linked nucleosides have a nucleobase sequence comprising the sequence recited in SEQ ID NO: 80 (tcttggttacatgaaatccc). |
申请公布号 |
NZ603339(A) |
申请公布日期 |
2015.01.30 |
申请号 |
NZ20110603339 |
申请日期 |
2011.04.29 |
申请人 |
ISIS PHARMACEUTICALS INC. |
发明人 |
FREIER SUSAN M.;MONIA BRETT P.;SIWKOWSKI ANDREW M. |
分类号 |
C12N15/11;C07H21/04 |
主分类号 |
C12N15/11 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|